Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)

Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosono, Makoto, Ikebuchi, Hideharu, Nakamura, Yoshihide, Nakamura, Nobutaka, Yamada, Takahiro, Yanagida, Sachiko, Kitaoka, Asami, Kojima, Kiyotaka, Sugano, Hiroyasu, Kinuya, Seigo, Inoue, Tomio, Hatazawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852188/
https://www.ncbi.nlm.nih.gov/pubmed/29333565
http://dx.doi.org/10.1007/s12149-018-1230-7
Descripción
Sumario:Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document.

Ejemplares similares